Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nextplat "expects to increase its equity holdings in Progressive Care to more than 50% of its issued and outstanding voting securities." This is the reason why they are not promoting RXMD because they need to absorb more shares to over 50% at such low price. Once that goal is achieved, it will be NEWS Time!
This can potentially save Progressive Care millions of dollars of PBM cost eavery year.
Major Victory for Florida Patients: NACDS Hails Enactment of Florida Bill Holding PBMs Accountable
“For far too long, PBM middlemen have manipulated Florida’s health care system, restricting patients’ access, driving up drug costs, and threatening pharmacies. With SB 1550 being signed into law today, Gov. Ron DeSantis and the Florida Legislature have sent a clear message that they are putting Florida patients first.”
https://www.nacds.org/news/major-victory-for-florida-patients-nacds-hails-enactment-of-florida-bill-holding-pbms-accountable/
We already know she’s leaving last year when her and Jay’s restricted shares were fully released to them. See my post on this topic last year.
This will NOT be just one, two or three joint ventures or partnerships for Nextplat in the next 80 days. This will be huge.
This will NOT be just one, two or three joint ventures or partnerships for Nextplat in the next 80 days. This will be huge.
In the next 80 days (by 7/20), Nextplat will form joint ventures, partnerships, and/or similar agreements with small businesses to produce goods for sale on the Tmall platform. Just wait for more big news to drop in the very near future. Another chance to preload guys, if you missed the "secrete Florida page" leak a month ago.
There’s more than just RXMD for NextPlat’s healthcare vision.
Healthcare E-Commerce Market is All Set to Reach $720.6 Billion in 2031, Rise in Digital Payments Drives the Growth.
https://www.linkedin.com/pulse/healthcare-e-commerce-market-all-set-reach-7206-billion-amy-wynette/
"Major healthcare e-commerce players in the market are Amazon.com, Inc., Alibaba Health Information Technology Limited, ...."
Healthcare E-Commerce Market is All Set to Reach $720.6 Billion in 2031, Rise in Digital Payments Drives the Growth.
https://www.linkedin.com/pulse/healthcare-e-commerce-market-all-set-reach-7206-billion-amy-wynette/
"Major healthcare e-commerce players in the market are Amazon.com, Inc., Alibaba Health Information Technology Limited, ...."
Mayor of Miami congratulates NextPlat and Alibaba on their partnership
Watch the video here:
https://www.nextplat.com/florida
Mayor of Miami congratulates NextPlat and Alibaba on their partnership
Watch the video here:
https://www.nextplat.com/florida
Hahahaha! I hit the lottery!
Yeah! $4.3!
Nextplat might be trying to set up a healthcare platform similar to Alibaba Health. Progressive Care might not sell products to China, but their healthcare platform is surely interesting.
Does anyone know Alibaba has a Alibaba Health platform?
Alibaba Health is China's largest e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on.
Alibaba Health is the flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. With a customer-centric approach, Alibaba Health fully utilizes its existing advantages in pharmaceutical e-commerce while exploring the new business model of internet healthcare service. With a “cloud-based infrastructure” as the foundation, the “cloud-based pharmacy” as the core, and the “cloud-based hospital” as the engine, the company leverages its leading digital technology and operation capabilities to provide affordable, convenient, efficient and reliable medical and healthcare services to hundreds of millions of families.
Alibaba Health is primarily engaged in the pharmaceutical direct sales business, pharmaceutical e-commerce platform business and healthcare and digital services business. Building on its strengths in internet and digital technologies, as well as its brand advantages and resources accumulated over the years, Alibaba Health now serves as an important bridge between physicians, pharmaceutical merchants and patients to address the challenges facing supply and demand. It has also established an integrated service platform to provide pharmaceutical and healthcare products both online and offline, further improving user experience.
https://www.alihealth.cn/en-us/aboutus
https://pitchbook.com/profiles/company/13303-45?utm_source=google&utm_medium=cpc&utm_campaign=Profile-Previews-US&adgroup=Profile-Previews-Company-Profiles&utm_term=&device=c&utm_content=&_bk=&_bt=572931937143&_bm=&_bn=g&_bg=119426138338&kwdaud=dsa-1046244901564&sfid=-dc_pcrid_572931937143_pkw__pmt__slid__productid__pgrid_119426138338_ptaid_dsa-1046244901564&gclid=CjwKCAjwrpOiBhBVEiwA_473dGfPYUQqg0iOahGWEKqMze8QUtutWAUnR_dVh20O1sf6eRy6kchoFBoCLLQQAvD_BwE#overview
Alibaba Group President J. Michael Evans will be the keynote speaker at the event. Tmall Global, Alibaba’s premierB2C cross-border platform for global brands to reach Chinese consumers, will also present the opportunities and consumer trends in China and discuss its variety of business solutions to help small and mid-sized entities launch in the market.
Alibaba Group President J. Michael Evans will be the keynote speaker at the event. Tmall Global, Alibaba’s premierB2C cross-border platform for global brands to reach Chinese consumers, will also present the opportunities and consumer trends in China and discuss its variety of business solutions to help small and mid-sized entities launch in the market.
Seriously, I think with the comment from the President of Alibaba, this can probably go above $10 quickly.
“We are excited to kick off a dynamic new e-commerce development program with Tmall here in SouthFlorida and bring the opportunity of new business in China to more American-based companies. Alibaba is one of the world’s preeminent e-commerce platform companies and the leader in serving the needs of millions of consumers and businesses throughout China and Asia. With our expanded relationship with Alibaba and Tmall, we are combining our collective expertise and capabilities to provide American businesses with a novel, turn-key international e-commerce solution that can provide them with access to potentially millions of new customers without having to invest in international operations and infrastructure”
-Charles M. Fernandez, Executive Chairman and CEO of NextPlat.
https://www.nextplat.com/florida
“We are excited to kick off a dynamic new e-commerce development program with Tmall here in SouthFlorida and bring the opportunity of new business in China to more American-based companies. Alibaba is one of the world’s preeminent e-commerce platform companies and the leader in serving the needs of millions of consumers and businesses throughout China and Asia. With our expanded relationship with Alibaba and Tmall, we are combining our collective expertise and capabilities to provide American businesses with a novel, turn-key international e-commerce solution that can provide them with access to potentially millions of new customers without having to invest in international operations and infrastructure”
-Charles M. Fernandez, Executive Chairman and CEO of NextPlat.
https://www.nextplat.com/florida
The President of Alibaba also commented on the NextPlat partnership!!! This is absolutely a huge news for the company!
“Demand for American-made goods in China continues to surge, creating valuable new growth opportunities for US companies with the capability to conduct international business overseas. Led by a highly experienced management team with deep roots in e-commerce, technology, and business. NextPlat is an ideal partner for Alibaba as we seek to assist more American businesses capitalize on the vast untapped potential ofthe Chinese consumer market,” said Michael Evans, President of Alibaba Group.
?-J. Michael Evans, President of Alibaba Group
https://www.nextplat.com/florida
The President of Alibaba also commented on the NextPlat partnership!!! This is absolutely a huge news for the company!
“Demand for American-made goods in China continues to surge, creating valuable new growth opportunities for US companies with the capability to conduct international business overseas. Led by a highly experienced management team with deep roots in e-commerce, technology, and business. NextPlat is an ideal partner for Alibaba as we seek to assist more American businesses capitalize on the vast untapped potential ofthe Chinese consumer market,” said Michael Evans, President of Alibaba Group.
?-J. Michael Evans, President of Alibaba Group
https://www.nextplat.com/florida
NextPlat Signs Merchant Sourcing Agreement with Alibaba Group Launches New E-Commerce Program to Provide American Businesses Easy Access to Chinese Consumer Market
https://ir.nextplat.com/news-events/press-releases/detail/102/nextplat-signs-merchant-sourcing-agreement-with-alibaba
Program to Leverage NextPlat's Global Capabilities and Partnership and Feature Alibaba's Tmall Global to Help Businesses Reach Millions of New Potential International Customers in China
COCONUT GROVE, FL / ACCESSWIRE / April 21, 2023 / NextPlat Corp (NASDAQ:NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-commerce provider, and Alibaba Group Holding Limited ("Alibaba") today announced they have entered into a merchant sourcing agreement whereby the two companies will collaborate to increase the sale of products produced and sold by American companies to the multi-trillion-dollar Chinese consumer market.
The agreement gives NextPlat the right to utilize Alibaba's Tmall Global e-commerce platform for use by NextPlat's Customers in the sale of their products to the Chinese consumer market and will provide NextPlat Customers a turn-key solution through which products can be sold to the Chinese consumer market. NextPlat Customers are defined as companies primarily based in and producing products in the United States and throughout all of the Americas.
NextPlat recently announced the launch of the first in a series of new e-commerce development programs designed to assist businesses to expand their existing online sales capabilities to reach new international customers in the Chinese market. The launch of the Florida e-commerce development program will be formally announced on Monday, April 24, 2023, at The Hangar Coconut Grove in Miami, Florida. NextPlat intends to rapidly expand this unique e-commerce development opportunity to businesses throughout the United States and all of North America as well as Central and South America. Alibaba Group President J. Michael Evans will be the keynote speaker at the event. Tmall Global, Alibaba's premier B2C cross-border platform for global brands to reach Chinese consumers, will also present the opportunities and consumer trends in China and discuss its variety of business solutions to help small and mid-sized entities launch in the market.
The initial e-commerce development program, aims to help Florida-based businesses and manufacturers market and sell their products to potentially millions of new customers. The new development program will feature NextPlat's turnkey global e-commerce solution for customers, and leverage NextPlat's relationships with key partners in Florida.
"We are excited to kick off a dynamic new e-commerce development program with Tmall here in South Florida and bring the opportunity of new business in China to more American-based companies. Alibaba is one of the world's preeminent e-commerce platform companies and the leader in serving the needs of millions of consumers and businesses throughout China and Asia. With our expanded relationship with Alibaba and Tmall, we are combining our collective expertise and capabilities to provide American businesses with a novel, turn-key international e-commerce solution that can provide them with access to potentially millions of new customers without having to invest in international operations and infrastructure," said Charles M. Fernandez, Executive Chairman and CEO of NextPlat.
"Demand for American-made goods in China continues to surge, creating valuable new growth opportunities for US companies with the capability to conduct international business overseas. Led by a highly experienced management team with deep roots in e-commerce, technology, and business, NextPlat is an ideal partner for Alibaba as we seek to assist more American businesses capitalize on the vast untapped potential of the Chinese consumer market," said Michael Evans, President of Alibaba Group.
To learn more about NextPlat's e-commerce development program or to attend, please visit www.nextplat.com/florida
To learn more about Tmall Global, please visit https://merchant.tmall.hk/en .
NextPlat Signs Merchant Sourcing Agreement with Alibaba Group Launches New E-Commerce Program to Provide American Businesses Easy Access to Chinese Consumer Market
https://ir.nextplat.com/news-events/press-releases/detail/102/nextplat-signs-merchant-sourcing-agreement-with-alibaba
Progressive Care Inc. (RXMD) Technology Solutions May Spark Rapid Expansion
https://www.biomedwire.com/progressive-care-inc-rxmd-technology-solutions-may-spark-rapid-expansion/
RMXD news indicates that a synergistic tech-healthcare collaboration with potential to ignite both growth and revenues is in the works
“Restructuring whiz” takes the helm as CEO, board chair
Through technology and proven processes, Progressive Care helps simplify chaos, improve care and reduce costs
Recent developments bode well for the future of Progressive Care (OTCQB: RXMD). On a mission to snag ever more market share using data management and analytical tools, the well-established healthcare company might be on the cusp of breaking out of slow-growth mode and into rapid expansion. Several factors are at play that could prove meaningful for the company and its stakeholders.
Recent news from the company indicates that a synergistic tech-healthcare collaboration is in the works that has the potential to ignite both growth and revenues. In a series of rapid-fire announcements, Progressive Care completed a recapitalization of its debt and received a strategic investment of $6 million from NextPlat Corp (NASDAQ: NXPL) (https://ibn.fm/5MlTc), a tech-driven, global e-commerce platform company that collaborates to capitalize on high-growth opportunities. All indications are that NextPlat has identified RXMD as a high-growth opportunity with significant upside potential.
In the transaction, NextPlat CEO Charles M. Fernandez, who “Fortune” Magazine called a “restructuring whiz” (https://ibn.fm/tWlm7), along with other investors, purchased an estimated $2.8 million of convertible debt in Progressive Care. He was also named chairman of the board of Progressive Care and assumed the role of CEO of the company shortly after. Commenting on the move, Fernandez stated in part, “I am taking on this role with the goal of maximizing the synergies that exist between NextPlat and Progressive Care” (https://ibn.fm/g921L).
Clearly, a tech infusion is underway at Progressive Care.
At its heart, Progressive Care is a tech-centric healthcare organization. Through its wholly owned subsidiaries, the company delivers personalized healthcare and pharmaceutical services along with technology that helps the managed healthcare industry reduce costs and improve quality of care (https://ibn.fm/lmFDQ). Technology appears be the only solution to administering the patchwork system of government programs and the jumbled maze of laws, rules, regulations, requirements, protocols, and politics that have pushed U.S. healthcare into the stratosphere of complexity and confusion.
Through technology and proven processes, Progressive Care helps simplify the chaos to improve care and reduce costs for patients, prescribers, providers, and managed-care entities. The company delivers these services through its two subsidiaries:
PharmcoRx, a full-service pharmacy that provides a complete healthcare ecosystem offering a wide range of services to patients and physicians (https://ibn.fm/cvflW). Major healthcare organizations’ customers in Florida give PharmcoRx rave reviews.
ClearMetrX, a data-management company, provides services that support healthcare organizations across the nation (https://ibn.fm/b2Spn). ClearMetrX recently launched the 340MetrX Platform, a proprietary software product that delivers 340B-covered entities actionable data insights, enabling them to best operate and maximize the benefits of the 340B program.
Information gleaned from Progressive Care’s website and its recent Form 10-K (https://ibn.fm/YZqQ2) suggests that a push into the booming Federal 340B Drug Pricing Program is coming. Seems to make even more sense given the recent backing of tech wizardry from NextPlat. Info from the Form 10-K states, “A key objective within organizations with access to large data collections is to harness the most relevant data and use it to optimize decision making. ClearMetrX developed the 340MetrX platform that retrieves dispensing pharmacy data to provide physicians and 340B covered entities with valuable and insightful reports and analytics to manage their operations.” Sophisticated software that serves a booming market providing actionable intelligence to manage costs and improve care could become quite valuable.
It’s little wonder then that the 340B program could be part of RXMD’s target market. 340B has experienced eye-popping growth, expanding at more than 4.5 times the pharmaceutical market growth rate from 2017 to 2020 (https://ibn.fm/gpY43) — and many expect that trend to continue or even accelerate. The program is so popular because 340B allows eligible healthcare clinics and hospitals to purchase outpatient drugs to treat the uninsured or underinsured at a 20–50% discount (https://ibn.fm/Bdf3D). Growing 76% from 2017, 340B program sales exceeded $80 billion in 2020 with 18.1% year-on-year growth vs. 2019.
Since 2006, Progressive Care has steadily been building its customer base, revenues, and a reputation for excellence. The development of the ClearMetrX software and expansion of PharmcoRx, combined with a synergistic tech-healthcare collaboration with NextPlat, could be the impetus that sparks rapid expansion and unleashes upside potential.
For more information, visit the company’s website at www.ProgressiveCareUS.com.
NOTE TO INVESTORS: The latest news and updates relating to RXMD are available in the company’s newsroom at https://ibn.fm/RXMD
If I were given a choice, I would not choose to be part of the universe, or part of any form of existence. Where did the first thing come from, by the way? I mean, the very first thing.
My midnight thought: “Universe is a POS”. No wonder it is so tiresome.
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, Florida
https://med.miami.edu/departments/dermatology
Welcome! Founded over 60 years ago, our Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery is one of the most respected and dynamic programs in the country. Striving for excellence in all of our missions, we take great pride and joy in working in education, research, clinical care, and community service.
Phillip Frost is the CEO and Chairman of OPKO Health, a Nasdaq company ($OPK)
https://www.opko.com/who-we-are/our-leadership/management-team
Dr. Frost has been the CEO and Chairman of OPKO since March 2007. Previously, Dr. Frost served at Teva Pharmaceutical Industries, Limited ("Teva") as both Chairman of the Board and Vice Chairman. Dr. Frost served as Chairman of the Board of Directors and CEO of IVAX Corporation from 1987 until its acquisition by Teva in January 2006. He also served as chairman for Key Pharmaceuticals, Ladenburg Thalmann Financial Services and was a director of Continucare Corporation and Castle Brands, Inc. He was also a Governor and Co-Vice-Chairman of the American Stock Exchange.
Dr. Frost is a past chairman and currently serves as a member of the Board of Trustees of the University of Miami, the Shanghai Institute for Advanced Immunochemical Studies in China, and as a Trustee of the Miami Jewish Home for the Aged and the Mount Sinai Medical Center. He also serves as a member of the Executive Committee of the Phillip and Patricia Frost Museum of Science. He is a past member of the Board of Trustees of the Scripps Research Institute, the Board of Regents of The Smithsonian Institution, and the Skolkovo Foundation Scientific Advisory Council in Russia.
Dr. Frost is a director of Cocrystal Pharma, Inc., a publicly traded biotechnology company developing new treatments for viral diseases.
Phillip Frost and Charles Fernandez sold IVAX to Teva Pharmaceuticals for $7.4 Billion Dollars!!!!!!!!!!!!!!!!!!!! Holy Moly! They are seriously rich!
Charles Fernandez also served in various positions within IVAX, a generic drugmaker, founded by Frost, including Director and Chairman of the Audit Committee of the Board of Directors. In January 2006, Teva acquired its U.S. rival Ivax Corporation for $7.4 billion!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
https://en.wikipedia.org/wiki/Charles_M._Fernandez
https://en.wikipedia.org/wiki/Teva_Pharmaceuticals
His accomplishments at IVAX:
Supervised all accounting, legal and regulatory activities at the largest generic pharmaceutical company in the United States.
• Assisted the Chairman and CEO in achieving international expansion that increased the enterprise value from $380 million dollars to more than $9 billion dollars.
• Completed financial and compliance analysis of over 100 mergers, acquisitions and development of new pharmaceuticals projects.
This is huge for RXMD. Major move is coming, whatever it maybe.
This is a MAJOR move by Nextplat for their healthcare business! What's about to come for RXMD will be spectacular!
Wow! Phillip Frost! In 1995, Fernandez moved into the Healthcare sector and co-founded Continucare, an outpatient service management company, with Phillip Frost.[9] In 1997, George Soros, became the largest shareholder of Continucare owning 19.5% via the Soros Fund.
https://en.wikipedia.org/wiki/Charles_M._Fernandez
Continucare Corporation is a publicly traded medical care service company with 18 medical centers located in Florida, United States. Founded in 1996 in Miami, Florida, the company provides its service on an outpatient basis and offers medical management services for independent medical facilities as well as independent physician affiliates a group of physicians and healthcare professionals .[2][3][4] As of December 2006, the company has served about 40,000 patients.[5] In 2011, the company was acquired Metropolitan Health Networks, Inc. at a cost of about $416 million.[6]
https://en.wikipedia.org/wiki/Continucare_Corporation
Don’t be so sure yet.
This event will disclose who they are partnering with in the Asia market and how this can help promote their healthcare business.
NextPlat Announces Completion of $6.0M Private Offering of Common Stock Priced Above Market
https://ir.nextplat.com/news-events/press-releases/detail/101/nextplat-announces-completion-of-6-0m-private-offering-of
The original announcement was to sell $6M at $1.75/share. Now after just 7 days, an accredited investor has bought all these $6M at a price above the market. Great move by NXPL.
NextPlat Announces Completion of $6.0M Private Offering of Common Stock Priced Above Market
https://ir.nextplat.com/news-events/press-releases/detail/101/nextplat-announces-completion-of-6-0m-private-offering-of
The original announcement was to sell $6M at $1.75/share. Now after just 7 days, an accredited investor has bought all these $6M at a price above the market. Great move by NXPL.
This will be revealed on Monday, April 24.
https://www.nextplat.com/florida